Rocket Doctor AI

Rocket Doctor AI ROCE

Delisted

The Return on Capital Employed (ROCE) of Rocket Doctor AI (TRUE.CN) as of Nov 16, 2026 is -759.52 %. In the previous year, Return on Capital Employed (ROCE) was 315.26 % — a change of -340.92% (lower).

ROCE

-759.52 %

YoY

-340.92%

Last updated:

In 2024, Rocket Doctor AI's return on capital employed (ROCE) was -759.52 %, a -340.92% increase from the 315.26 % ROCE in the previous year.

The Rocket Doctor AI ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2017
262.23 CAD
Jan 1, 2018
-701.00 CAD
Jan 1, 2019
-192.06 CAD
Jan 1, 2020
1,104.56 CAD
Jan 1, 2021
-12,645.13 CAD
Jan 1, 2022
173.05 CAD
Jan 1, 2023
315.26 CAD
Jan 1, 2024
-759.52 CAD
The Rocket Doctor AI ROCE history
YEARROCEYoY
-759.52 %-340.92%
315.26 %+82.18%
173.05 %-101.37%
-12,645.13 %-1,244.81%
1,104.56 %-675.11%
-192.06 %-72.60%
-701.00 %-367.32%
262.23 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Rocket Doctor AI Stock analysis

What does Rocket Doctor AI do? Treatment.com AI Inc generates revenue through its Treatment Digital Health App, a symptom assessment tool developed by a global team of doctors and engineers. The app provides predictive health insights using disease rate estimates, geographic variation data, and medical research, targeting patients and caregivers seeking informed health decisions. The company also offers medical education solutions and clinical advisor services, serving healthcare professionals and institutions globally. Revenue streams include subscriptions for app access and tailored medical education programs. The Treatment Digital Health App is designed for widespread use, offering advanced medical knowledge access to users worldwide. Medical clinic solutions are integrated into the platform, supporting healthcare providers in decision-making. Clinical advisor services leverage the AI platform to assist clinics and institutions with specialized medical guidance. These offerings are marketed to healthcare consumers, clinics, and educational institutions as part of the company's global healthcare technology strategy. Treatment.com AI Inc's business model focuses on AI-driven health solutions, with the Treatment Digital Health App as its primary product. The app's predictive health assessments are updated regularly by medical professionals, ensuring relevance and accuracy. The company monetizes through direct consumer subscriptions and B2B partnerships with medical clinics and educational providers, emphasizing global accessibility and evidence-based medical insights. Rocket Doctor AI is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Rocket Doctor AI's Return on Capital Employed (ROCE)

Rocket Doctor AI's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Rocket Doctor AI's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Rocket Doctor AI's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Rocket Doctor AI’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Rocket Doctor AI stock

Return on Capital Employed (ROCE) of Rocket Doctor AI is -759.52 % in 2024.

Return on Capital Employed (ROCE) of Rocket Doctor AI changed from 315.26 % to -759.52 %, representing a -340.92% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Rocket Doctor AI since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Rocket Doctor AI with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Rocket Doctor AI

All Key Metrics — Rocket Doctor AI